Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
Translational Medicine Communications Open Access 23 August 2021
-
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Nature Communications Open Access 01 March 2021
-
HIV-1 subverts the complement system in semen to enhance viral transmission
Mucosal Immunology Open Access 10 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wyatt, R. & Sodroski, J. Science 280, 1884–1888 (1998).
Parren, P.W. & Burton, D.R. Adv. Immunol. 77, 195–262 (2001).
Johnson, W.E. & Desrosiers, R.C. Annu. Rev. Med. 53, 499–518 (2002).
Saphire, E.O. et al. Science 293, 1155–1159 (2001).
Calarese, D.A. et al. Science 300, 2065–2071 (2003).
Zwick, M.B. et al. J. Virol. 75, 10892–10905 (2001).
Stanfield, R.L., Gorny, M.K., Williams, C., Zolla-Pazner, S. & Wilson, I.A. Structure (in the press).
Sharon, M. et al. Structure (Camb) 11, 225–236 (2003).
Proudfoot, A.E. et al. J. Biol. Chem. 276, 10620–10626 (2001).
Labrijn, A.F. et al. J. Virol. 77, 10557–10565 (2003).
Choe, H. et al. Cell 114, 161–170 (2003).
Golding, H. et al. J. Virol. 76, 6780–6790 (2002).
Sanders, R.W. et al. J. Virol. 76, 8875–8889 (2002).
Yang, X., Wyatt, R. & Sodroski, J. J. Virol. 75, 1165–1171 (2001).
Grundner, C., Mirzabekov, T., Sodroski, J. & Wyatt, R. J. Virol. 76, 3511–3521 (2002).
Srivastava, I.K. et al. J. Virol. 77, 11244–11259 (2003).
Pantophlet, R., Wilson, I.A. & Burton, D.R. J. Virol. 77, 5889–5901 (2003).
Fouts, T. et al. Proc. Natl. Acad. Sci. USA 99, 11842–11847 (2002).
Klausner, R.D. et al. Science 300, 2036–2039 (2003).
Kwong, P.D., Wyatt, R., Sattentau, Q.J., Sodroski, J. & Hendrickson, W.A. J. Virol. 74, 1961–1972 (2000).
Selvarajah, S. & Burton, D.R. Accelerating AIDS Vaccine Development: Challenges and Opportunities (eds. Kahn, P., Gust, P. & Koff, W.) (Horizon Scientific Press, Norwich, UK, in the press).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Burton, D., Desrosiers, R., Doms, R. et al. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5, 233–236 (2004). https://doi.org/10.1038/ni0304-233
Issue Date:
DOI: https://doi.org/10.1038/ni0304-233
This article is cited by
-
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
Translational Medicine Communications (2021)
-
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Nature Communications (2021)
-
HIV-1 subverts the complement system in semen to enhance viral transmission
Mucosal Immunology (2021)
-
Asymmetric opening of HIV-1 Env bound to CD4 and a coreceptor-mimicking antibody
Nature Structural & Molecular Biology (2019)
-
Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions
Nature Communications (2019)